《Acta Pharmacologica Sinica》雜志的最新年發文量為156篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在藥學領域的學術影響力。
該刊聚焦于醫學-藥學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 約2月 。
Acta Pharmacologica Sinica 雜志發文統計
文章名稱引用次數
- miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges64
- Exosomes: new molecular targets of diseases47
- Salvia miltiorrhiza Burge (Danshen): a golden herbal medicine in cardiovascular therapeutics42
- Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools35
- Leptin, cardiovascular diseases and type 2 diabetes mellitus35
- Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1 alpha deacetylation25
- Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases24
- The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases22
- Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway20
- KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells17
國家/地區發文量
- CHINA MAINLAND600
- USA107
- Canada29
- Australia13
- England8
- Japan8
- Singapore8
- South Korea8
- GERMANY (FED REP GER)6
- Greece6
